echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Immunology News > A new drug for Hunter syndrome, the Ado sulfate enzyme beta injection, has been approved in China.

    A new drug for Hunter syndrome, the Ado sulfate enzyme beta injection, has been approved in China.

    • Last Update: 2020-09-24
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    On September 3rd, Noah Pharmaceuticals/Beihai Kangcheng filed an application for the listing of Adolfate beta injections in China, which was approved by the State Drug Administration for the treatment of Hunter syndrome.
    Hunt syndrome, also known as type II mucosal polysaccharide storing disorder, is a rare, disabling, and fatal genetic disorder caused by a lack of 2-sulphatease, an enzyme necessary to break down glycosamine (GAGs) in the body.
    deficiency of 2-sulphate enzymes can lead to the accumulation of GAG in patients and lead to serious bone, tissue, nerve and multi-organ complications, which can eventually lead to death.
    is more common in East Asia and is currently incurable, with standard therapy being enzyme replacement therapy or palliative care.
    Ado sulfate enzyme beta (English trade name: Hunterase) is a recombinant person Adulystic acid-2-sulphate enzyme replacement therapy, developed by GC Pharma, Beihai Kangcheng owns the Chinese interest in the drug.
    source: Medical Rubik's Cube!-- the end of the content display -- !-- determine whether the login is over.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.